With that in mind, let's examine two pharma stocks that are incredibly cheap and which are worth buying right now, assuming ...

Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market ...

Amid a transformation effort under CEO Christophe Bourdon, Danish dermatology expert Leo Pharma is embarking on another round ...

Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...

West Pharmaceutical Services' stock has been sluggish, trading near its 52-week low, with analysts downgrading estimates and ...

On Sunday, The Guardian issued an article that spoke of a UK study that could transform how cancer is treated. The ...

In the period between January and September, the Indian pharmaceutical market grew by an average of 7.6%, but volume growth ...

Generic drug giant Teva Pharmaceuticals has agreed to pay $450 million to settle two cases brought by the Department of ...

Marshall Wace LLP reduced its holdings in shares of Nuvectis Pharma, Inc. (NASDAQ:NVCT – Free Report) by 32.4% in the second quarter, according to its most recent Form 13F filing with the Securities ...

NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2024 of $0.21 per Class A ...

BALLERUP, Denmark-- ( BUSINESS WIRE )--LEO Pharma today announced its commitment to achieving a net-zero climate target by ...

Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on Alnylam Pharma (ALNY – Research Report) today and set a price target of ...